Metalpha Technology (MATH) appoints Isabella He to lead global IR

Rhea-AI Filing Summary

Metalpha Technology Holding Limited announces that consultant Mr. Liyang Lu has concluded his consultancy and all other services with the company effective August 22, 2025, to pursue personal endeavors.

Separately, Metalpha appoints Ms. Isabella He as its new Head of Institutional & IR, effective September 22, 2025. She brings extensive experience in investor relations and investment banking, having held senior roles at I-Mab Biopharma, Genor Biopharma, and prior positions at Citigroup, Morgan Stanley, UBS, Oppenheimer and Mainfirst Securities. A graduate in Economics from the London School of Economics, she will lead the company’s global investor relations strategy and focus on expanding and strengthening relationships with institutional investors.

The report also states that this Form 6-K is incorporated by reference into Metalpha’s existing Form S-8 registration statements.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

For the month of September 2025

Commission File Number: 001-38208

Metalpha Technology Holding Limited

Suite 6703-04, Central Plaza

18 Harbour Road, Wan Chai,

Hong Kong, China

(Address of Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒        Form 40-F  ☐

ADVISOR TRANSITION AND HEAD OF INSTITUTIONAL & IR APPOINTMENT

Metalpha Technology Holding Limited (the “Company”) notes that Mr. Liyang Lu has concluded his consultancy and all other services with the Company, effective August 22, 2025, to pursue personal endeavors.

Separately, the Company announces the appointment of Ms. Isabella He as its new Head of Institutional & IR, effective September 22, 2025.

Ms. Isabella He has extensive experience in investor relations and investment banking at leading financial institutions and public companies. Prior to joining the Company, Ms. He served as Vice President, Global Head of IR and Strategy Operating and various positions at I-Mab Biopharma (IMAB.US) and Genor Biopharma (6998.HK). She previously served as Vice President of China Equity Sales at Citigroup and held various positions at Morgan Stanley, UBS, Oppenheimer and Mainfirst Securities. Ms. He received her Bachelor of Science degree in Economics from the London School of Economics (LSE).

Ms. He will mainly be responsible for leading the Company’s global investor relations strategy, expanding and strengthening relationships with institutional investors.

INCORPORATION BY REFERENCE

This current report on Form 6-K shall be deemed to be incorporated by reference into the Company’s registration statements on Form S-8 (File No. 333-255251 and File No. 333-283335) and to be a part thereof from the date on which this current report is furnished, to the extent not superseded by documents or reports subsequently filed or furnished.

1

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	Metalpha Technology Holding Limited
	By:	/s/ Bingzhong Wang
	Name:	Bingzhong Wang
	Title:	Chief Executive Officer and Chairman of the Board of Directors

Date: September 17, 2025

2

FAQ

What executive change did Metalpha Technology Holding Limited (MATH) disclose in this 6-K?

Metalpha disclosed that consultant Mr. Liyang Lu has concluded his consultancy and all other services with the company, effective August 22, 2025, to pursue personal endeavors.

Who is the new Head of Institutional & IR at Metalpha Technology Holding Limited (MATH)?

Metalpha appointed Ms. Isabella He as its new Head of Institutional & IR, effective September 22, 2025. She will lead global investor relations strategy and focus on institutional investor relationships.

What relevant experience does Isabella He bring to her role at Metalpha (MATH)?

Isabella He has extensive investor relations and investment banking experience. She previously served as Vice President, Global Head of IR and Strategy Operating and in other roles at I-Mab Biopharma and Genor Biopharma, and worked at Citigroup, Morgan Stanley, UBS, Oppenheimer and Mainfirst Securities.

What are Isabella He’s main responsibilities at Metalpha Technology Holding Limited (MATH)?

Ms. He will mainly be responsible for leading Metalpha’s global investor relations strategy and for expanding and strengthening relationships with institutional investors.

How is this Metalpha (MATH) Form 6-K used in relation to its registration statements?

This Form 6-K is incorporated by reference into Metalpha’s registration statements on Form S-8 (File No. 333-255251 and File No. 333-283335) and becomes part of those registration statements from the date it is furnished, to the extent not later superseded.

Who signed the Metalpha Technology Holding Limited (MATH) 6-K report?

The report was signed on behalf of Metalpha Technology Holding Limited by Bingzhong Wang, who is the company’s Chief Executive Officer and Chairman of the Board of Directors.